| |
| |
|
| Insider
Information: |
Knopf John L |
| Relationship: |
CEO and President, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
214,084 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,267,515 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
214,084 |
|
|
| Total
Value |
$38,267,515 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
CEO and President, Dir... |
2016-11-09 |
214,084 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-11-09 |
4 |
OE |
$5.08 |
$545,805 |
D/D |
100,000 |
314,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-11-09 |
4 |
AS |
$32.19 |
$3,219,000 |
D/D |
(100,000) |
214,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-07 |
4 |
OE |
$1.80 |
$171,000 |
D/D |
95,000 |
214,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-06 |
4 |
AS |
$33.58 |
$1,399,895 |
D/D |
(41,477) |
119,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-06 |
4 |
OE |
$5.28 |
$218,999 |
D/D |
41,477 |
160,561 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-05 |
4 |
OE |
$5.28 |
$161,045 |
D/D |
30,501 |
149,585 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-05 |
4 |
AS |
$33.18 |
$1,014,509 |
D/D |
(30,501) |
119,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-01 |
4 |
AS |
$34.18 |
$973,055 |
D/D |
(28,022) |
119,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-07-01 |
4 |
OE |
$5.28 |
$121,556 |
D/D |
23,022 |
147,106 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-20 |
4 |
AS |
$33.17 |
$855,355 |
D/D |
(25,787) |
124,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-20 |
4 |
OE |
$5.08 |
$130,998 |
D/D |
25,787 |
149,871 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-19 |
4 |
OE |
$5.08 |
$191,125 |
D/D |
37,623 |
161,707 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-19 |
4 |
AS |
$33.04 |
$1,243,064 |
D/D |
(37,623) |
124,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-18 |
4 |
AS |
$33.04 |
$1,208,934 |
D/D |
(36,590) |
124,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-05-18 |
4 |
OE |
$5.08 |
$122,377 |
D/D |
24,090 |
160,674 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2016-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
136,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-10-07 |
4 |
OE |
$5.08 |
$96,520 |
D/D |
19,000 |
138,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-10-07 |
4 |
AS |
$24.01 |
$463,288 |
D/D |
(19,000) |
119,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-09-14 |
4 |
OE |
$0.40 |
$3,400 |
D/D |
8,500 |
119,084 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
89,000 |
110,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-09-08 |
4 |
AS |
$29.16 |
$573,890 |
D/D |
(19,000) |
21,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-09-08 |
4 |
OE |
$5.08 |
$96,520 |
D/D |
19,000 |
40,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-08-10 |
4 |
AS |
$28.51 |
$542,045 |
D/D |
(19,000) |
21,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-08-10 |
4 |
OE |
$5.08 |
$96,520 |
D/D |
19,000 |
40,584 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
CEO and President |
• • – |
2015-07-30 |
4 |
OE |
$0.40 |
$1,600 |
D/D |
4,000 |
21,584 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
